Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Advancing foundational research from UCLA and Migal – Galilee Research Institute, ImmPact is working on T-cell therapies for liquid and solid cancers.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

UCL spinout Ori Biotech has raised more than $100m in a series B round led by Novalis LifeSciences, just over a year after closing a $30m series A round.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Eikon Therapeutics was co-founded by UC Berkeley researchers, one of whom has already received a Nobel Prize for the underlying technology.

All existing shareholders contributed to the Marine Biological Laboratory spinout’s series B round, following a $91.5m series A in mid-2020.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.